FDA NDC Directory · JSON-LD · Markdown

PERTZYE

NDC 59767-004 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Generic namepancrelipase
Labeler / ManufacturerDigestive Care, Inc.
Marketing categoryBiologic License Application · App BLA022175
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsPANCRELIPASE AMYLASE (15125 [USP'U]/1)
PANCRELIPASE LIPASE (4000 [USP'U]/1)
PANCRELIPASE PROTEASE (14375 [USP'U]/1)
Marketing started20161006
Package count2

External sources

Source: openFDA. Public-domain (CC0).